Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong You

Showing results (811-820 of 904) with videos related to

Pageof 91
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 8, 2020
A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver InjuryQiuju Tian, Ruiyuan Yang, Yan Wang, et al.
Journal of Gastroenterology and Hepatology|October 27, 2018
Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from ChinaSha Chen, Weijia Duan, Min Li, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 2, 2009
[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]Wan-li Kang, Yan-guang Xie, Wei-guo Tan, et al.
Journal of Digestive Diseases|June 25, 2019
Impact of reimbursement program on liver-related mortality in patients with chronic hepatitis B in Beijing, ChinaMin Li, Yuan Yuan Kong, Shan Shan Wu, et al.
Scientific Reports|February 16, 2018
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapyYameng Sun, Jialing Zhou, Xiaoning Wu, et al.
Journal of Hepatology|August 29, 2022
Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosisQi Wang, Hong Zhao, You Deng, et al.
Critical Reviews in Food Science and Nutrition|September 20, 2022
Label compliance for ingredient verification: regulations, approaches, and trends for testing botanical products marketed for "immune health" in the United StatesHong You, Evelyn J Abraham, Jason Mulligan, et al.
Acta Pharmacologica Sinica|February 5, 2026
Asiatic acid promotes CD8<sup>+</sup> T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinomaYu-Chuan Chen, Xue-Lian Gao, Ge Zeng, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosisYou Deng, Haiyan Kang, Huiling Xiang, et al.
Orphanet Journal of Rare Diseases|August 4, 2022
Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patientsWen An, Zhen Wu, Min Li, et al.
Pageof 91

Showing results (811-820 of 904) with videos related to

Sort By:
Pageof 91
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 8, 2020
A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver InjuryQiuju Tian, Ruiyuan Yang, Yan Wang, et al.
Journal of Gastroenterology and Hepatology|October 27, 2018
Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from ChinaSha Chen, Weijia Duan, Min Li, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 2, 2009
[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]Wan-li Kang, Yan-guang Xie, Wei-guo Tan, et al.
Journal of Digestive Diseases|June 25, 2019
Impact of reimbursement program on liver-related mortality in patients with chronic hepatitis B in Beijing, ChinaMin Li, Yuan Yuan Kong, Shan Shan Wu, et al.
Scientific Reports|February 16, 2018
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapyYameng Sun, Jialing Zhou, Xiaoning Wu, et al.
Journal of Hepatology|August 29, 2022
Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosisQi Wang, Hong Zhao, You Deng, et al.
Critical Reviews in Food Science and Nutrition|September 20, 2022
Label compliance for ingredient verification: regulations, approaches, and trends for testing botanical products marketed for "immune health" in the United StatesHong You, Evelyn J Abraham, Jason Mulligan, et al.
Acta Pharmacologica Sinica|February 5, 2026
Asiatic acid promotes CD8<sup>+</sup> T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinomaYu-Chuan Chen, Xue-Lian Gao, Ge Zeng, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosisYou Deng, Haiyan Kang, Huiling Xiang, et al.
Orphanet Journal of Rare Diseases|August 4, 2022
Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patientsWen An, Zhen Wu, Min Li, et al.
Pageof 91